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Abstract 
Since the 1940s, Staphylococcus aureus has adapted to the use of different antimicrobials to treat infections. Although 
S. aureus can act as a commensal bacterium, some strains are facultative pathogens and acquiring them can be fatal. 
In particular, treating infections caused by S. aureus with acquired antimicrobial resistance is problematic, as their 
treatment is more difficult. Some of these S. aureus variants are methicillin‑resistant S. aureus (MRSA) with prevalence 
across the globe in health‑care facilities, community settings and on livestock farms. Apart from humans, MRSA can 
colonise other animal species, and because of this, resistance to new antimicrobials can appear and jump between 
species. Livestock and companion animals are particularly important in this regard considering the relatively high 
usage of antimicrobials in these species. There is a risk to humans who come into direct contact with animals acquir‑
ing MRSA but there is also the risk of animals acquiring MRSA from colonised humans. In this review, we summarise 
studies conducted worldwide to characterise the prevalence of MRSA in veterinarians, farmers and other personnel 
who come into close contact with animals. Finally, alternative treatment, preventive measures and on‑farm strategies 
to reduce MRSA introduction to a farm and carriage within a herd are discussed.
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Introduction
Staphylococcus aureus is a Gram-positive catalase-posi-
tive bacterium which is commonly found on the skin and 
mucosa of humans and animals [1–3]. The anterior nares 
of humans are one of the most frequently colonised sites 
and about 30% of the human population is colonised with 
S. aureus [3, 4]. Although S. aureus is usually classified 
as a commensal bacterium, it is a facultative pathogen, 
which can potentially cause several diseases from mild 
skin lesions to severe and potentially fatal infections [5]. 
As a commensal bacterium, S. aureus colonises its host 
without impacting the health of the host. Depending on 
the persistence of carriage, hosts can be persistent car-
riers,  intermittent carriers, or non-carriers at all, if the 
bacterium rarely colonises the host, and when it does, 
the colonisation is transient and does no last longer than 
about two weeks [6]. However, nasal swabs from persis-
tent carriers usually yield the same MRSA strains over 
time, and because of the facultative pathogenicity of S. 
aureus, persistent carriers are at a higher risk of develop-
ing an infection [6].
Within a few years of the introduction of penicillin in 
the 1940s, the first cases of penicillin-resistant S. aureus 
were reported [7]. Resistance was obtained through 
the acquisition of plasmids that contained the ß-lacta-
mase gene (blaZ), which produce an enzyme capable of 
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breaking down the β-lactam ring of penicillin and other 
antibiotics [8–10]. The β-lactam ring of penicillin causes 
bacterial lysis by binding to penicillin-binding proteins 
(PBP), which are needed for cross-linking the peptidogly-
can chains of the cell wall [11].
Methicillin, a new antibiotic with resistance to 
β-lactamase was developed two decades later, in 1960, 
and in less than two years, the first methicillin-resistant 
S. aureus (MRSA) appeared [12, 13]. This new resist-
ance was driven by the acquisition of the mecA gene, 
which encodes the penicillin-binding protein 2a (PBP2a), 
a slightly different PBP that possesses low affinity for 
β-lactam antibiotics [14].
Later on, in the 1980s and 1990s, MRSA strains spread 
across the world carrying multidrug resistant traits and 
being one of the most important agents of nosocomial 
infection [5]. These MRSA strains were called hospital-
acquired MRSA (HA-MRSA), as they were commonly 
found in hospitals and health care facilities.
In parallel with the spread of HA-MRSA, control 
measures were applied in hospital settings to prevent 
nosocomial transmission of MRSA [15]. These preven-
tive measures reduced HA-MRSA prevalence in several 
countries. However, infections caused by new MRSA 
strains started to increase in communities outside the 
hospital setting in the 1990s [16, 17]. These strains 
which could spread rapidly among groups of healthy 
individuals were called community-acquired MRSA 
(CA-MRSA) [18].
In 2004, a new MRSA strain was found colonising the 
daughter of a pig farmer in the Netherlands [19]. Both 
parents and a pig on the family farm carried the same 
strain, which was characterized by the presence of the 
mecA gene. This strain was different from those usually 
found in HA-MRSA and CA-MRSA, as it was impossible 
to classify it using the standard method of pulsed-field 
gel electrophoresis (PFGE) with restriction endonucle-
ase SmaI. Although other studies previously reported a 
linkage between animal and human MRSA colonisation, 
this was the first study to demonstrate the transmission 
of MRSA between animals and humans. Later on, sev-
eral other studies reported this in other countries. The 
term livestock-associated MRSA (LA-MRSA) was used 
to refer to this third group of MRSA strains which were 
considered a reservoir in livestock animals [20].
There are several methods for screening and typ-
ing MRSA strains: spa sequence typing; multilocus 
sequence typing (MLST); staphylococcal cassette chro-
mosome mec (SCCmec) typing; PFGE; and multilo-
cus variable-number tandem repeat (VNTR) analysis 
(MLVA) (reviewed in [21, 22]). Based on MLST, strains 
are assigned to a sequence type (ST) after sequencing 
seven endogenous genes. Identical strains by MLST are 
assigned to the same ST, while strains with closely related 
STs may belong to the same clonal complex (CC) lineage 
(e.g., CC398). Another most commonly used method is 
spa typing, based on sequencing the variable X region 
of the S. aureus surface protein A (spa) gene and assign-
ing the strains to a spa type based on the different pol-
ymorphisms found (e.g., t011). The last method that 
has received most attention is SCCmec typing, which 
sequences and classifies the strains based on the differ-
ences in mobile genetic elements (MGE) including the 
aforementioned mecA gene (e.g., SCCmec IV). Despite 
the efforts in classifying the different MRSA strains 
found, the epidemiology of MRSA colonisation is chang-
ing. Strains of CA-MRSA can share genes between both 
LA- and HA- MRSA [23], and some clones are present in 
more than one classification group, blurring the distinc-
tion between strains [24–26].
LA-MRSA strains can be transmitted between different 
animal species and to humans who come in close contact 
with colonised animals, such as veterinarians and farm 
workers. However, colonised humans can also transmit 
LA-MRSA to other humans and between animal settings. 
In this review, we have summarised studies conducted 
worldwide to assess the prevalence of MRSA in person-
nel who come into close contact with animals. We also 
discuss preventive measures to avoid MRSA introduction 
onto a farm, alternative treatments and on-farm strate-
gies to reduce or eradicate MRSA carriage within a herd.
MRSA transmission between humans, animal production 
and companion animals
MRSA can be transmitted from vertebrate animals 
to humans. Likewise, humans also act as a reservoir 
for the transmission of S. aureus to vertebrate ani-
mals. Infections that can be present in both humans 
and animals and transmitted in both directions, such 
as S. aureus infections, are defined as “amphixenoses” 
[27]. The first reported incident of MRSA colonisa-
tion in livestock happened in Belgium in the early 
1970s, affecting the milk of cows with bovine mastitis 
[28]. Despite most of the isolates having been similar 
to common bovine strains, a human-to-animal trans-
mission of a new MRSA strain acquired by the farmer 
seems more likely due to the observed antimicrobial 
characteristics. Since then, MRSA colonisation has 
been reported in dogs, cats, horses, cattle, pigs, rabbits 
and poultry [29–32]. It has even been described in wild 
birds such as magpies and vultures [33]. The first ani-
mal-to-human transmission of S. aureus was reported 
in dairy sheep [34]. Shortly after, the first case of MRSA 
transmission from animal to human, including human-
to-human transmission of the same strain was reported 
[19]. Other interspecies transmission have been 
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described in household pets, which can be colonised 
with the same strains as their owners [35]. Nonetheless, 
despite the potential of S. aureus to colonise domestic 
and livestock animals, the primary reservoirs of LA-
MRSA in affected countries are those animals in inten-
sive systems (i.e., pigs, veal calves, and broilers) [36].
S. aureus is usually transmitted by direct contact with 
colonised skin or with a mechanical vector [37]. In live-
stock systems, the most important ways of introducing 
MRSA onto a farm are the movement of MRSA colo-
nised animals from one farm to another, direct contact 
with colonised humans and through animal contact 
with contaminated transport vehicles [38–40]. Another 
indirect way of transmitting MRSA between species is 
through the environment. S. aureus has a half-life of 
5  days in dust, but it can survive in it for weeks [41]. 
These small particles can be transported to other farms 
on vehicles, and farm-workers can expose their fami-
lies to the bacterium by bringing home dust covered 
clothes. Dust can also be transported by the wind along 
with other substances; airborne staphylococci has been 
detected at 477 m from a commercial broiler barn, and 
up to 530 m in theory [42]. Indeed, airborne-transmis-
sion of MRSA in hospitals [43], and to personnel that 
work more than 20  h per week in farm barns [44] is 
also possible. Apart from direct contact with animals or 
humans in contact with them, MRSA can also be trans-
mitted through food production systems. Animals can 
act as a reservoir for antimicrobial-resistant bacteria 
and their products, such as meat, milk and eggs, can be 
a means of transmission of these bacteria to the con-
sumer [45, 46]. However, the risk of acquiring MRSA 
through food appears to be low [36].
Despite certain S. aureus strains being closely adapted 
to a specific host, they can be transmitted to other spe-
cies [47–49]. These colonisations outside their preferred 
hosts are usually transient and generally do not last long 
[50], although some can be transmitted and sustained 
among the new host species [47, 49]. Moreover, MRSA 
strains continuously evolve in the host, and can even be 
replaced by other strains [51]. There are several factors 
that can influence MRSA transmission between animals 
and humans. The intensity/duration of animal contact 
is one such; farmers working more hours in a calf stable 
were more often carriers than farmers working fewer 
hours [50, 52]. In the absence of animal contact, LA-
MRSA carriage was often reduced or lost, although some 
persistent carriers were reported [50]. Furthermore, the 
number of MRSA-positive animals within the farm also 
increases the probability of MRSA being transmitted to 
the farmer [52]. Following this trend, people living in 
areas with a higher livestock density (pigs, cattle, and 
veal calves) or in proximity to areas where pig manure 
is applied to crop fields are also at a higher risk of being 
colonised by LA-MRSA [53, 54].
LA‑MRSA colonisation in humans in close contact 
with animals
Most of the LA-MRSA strains that colonise humans will 
not necessarily cause an infection, and when they occur 
they are usually less severe than those caused by HA- and 
CA-MRSA [55]. In addition, LA-MRSA strains repre-
sent a small proportion (3.9%) of the isolated MRSA in 
humans in the European Union, but their proportion was 
higher (≥ 10%) in five countries (Belgium, Denmark, the 
Netherlands, Slovenia and Spain) [56]. However, every S. 
aureus strain has the potential to evolve into a life-threat-
ening pathogen [57]. For instance, in 2014, four patients 
died from LA-MRSA bacteraemia in Denmark, raising 
the concern regarding LA-MRSA in the European Union 
[56]. Today, hospital anamnesis usually includes ques-
tions to target farm workers or personnel in close contact 
with animal production settings due to their increased 
risk of being colonised with MRSA.
Several studies have concluded that humans in close 
contact with animals have greater risk of being colonised 
by LA-MRSA than the rest of the population [58–62]. 
Although some studies have reported that veterinarians 
are more likely to be MRSA carriers than farmers [60, 
62], meta-analyses of published data established that live-
stock workers are at a higher risk to be colonised with 
LA-MRSA, more so if they are pig farmers [63, 64]. How-
ever, colonisation in veterinarians is a potential thread 
for MRSA spread among farms. To assess the prevalence 
of MRSA colonisation in veterinarians, an NCBI Data-
base search for the terms “veterinarian”, “prevalence” and 
“MRSA” was conducted. The resulting studies are sum-
marized in Table  1, while the spa types carried by the 
humans analysed are reported in Fig. 1.
Prevalence of MRSA carriage  in the general human 
population has been reported to be in the range of 0.8–
1.3% [79]. When the data presented in Table  1 relating 
to veterinary personnel is considered, the prevalence 
reported ranged between 0 and 50% with an overall 
mean prevalence of 8% across studies, as most studies 
described a prevalence less than 10%. Most of the studies 
considered in this review were conducted in Europe and 
the most commonly reported strain was CC398 (usu-
ally spa type t011), considered the dominant LA-MRSA 
strain in Europe. Some other strains such as CC5 (usually 
spa type t002) were reported as more dominant in Asia. 
HA-MRSA and CA-MRSA strains were also reported in 
these studies, making it difficult to discern the host pref-
erence of MRSA strains. Despite CC398 being considered 
the classical LA-MRSA strain, it originated in humans 
as methicillin-susceptible S. aureus [95]. Nowadays, the 
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Table 1 Prevalence of MRSA in veterinarian personnel and animal workers reported in studies conducted worldwide
Study Year conducted Country Prevalence N Population
(Chen et al., 2020) [65] 2019 China 31.71% 41 Veterinarians (veterinary hospitals)
(Schmidt et al., 2020) [66] Aug 2018‑Jan 2019 Switzerland 7.07% 99 Veterinary personnel from animal companion 
clinics
(Kittl et al., 2020) [67] 2017 Switzerland 5.13% 156 Farmers
(Kittl et al., 2020) [67] 2017 Switzerland 6.60% 212 Veterinarians
(Neradova et al., 2020) [68] 2017 Czech Republic 6.72% 134 Veterinary personnel
(Taus et al., 2019) [69] 2017 Austria 13.40% 261 Veterinarians
(Taus et al., 2019) [69] 2017 Austria 38.30% 47 Swine veterinarians
(Taus et al., 2019) [69] 2017 Austria 7.90% 214 Non‑swine veterinarians
(Verkola et al., 2019) [70] 2016 Finland 0.30% 320 Veterinarians
(Tabatabaei et al., 2019) [71] Nov 2012—Mar 2013 Iran 4.00% 50 Veterinary personnel
(Sun et al., 2017) [72] 2012 USA 9.50% 66 Swine veterinarians
(Wang et al., 2017) [61] Nov 2013‑Nov 2014 China 5.10% 335 Farmers and veterinarians (pig‑related workers)
(Mroczkowska et al., 2017) [60] Aug 2010‑Nov 2012 Poland 3.20% 283 Pig farmers
(Mroczkowska et al., 2017) [60] Aug 2010‑Nov 2012 Poland 10.50% 38 Veterinarians
(Post et al., 2017) [73] 2013 Worldwide 5.00% 60 Veterinary surgeons
(Walter et al., 2016) [74] 2008–2009 Germany 9.00% 695 Veterinarian attending to different species
(Walter et al., 2016) [74] 2008–2009 Germany 8.53% 516 Veterinarian in contact with cattle
(Walter et al., 2016) [74] 2008–2009 Germany 14.52% 365 Veterinarian in contact with pigs
(Steinman et al., 2015) [75] 2012 Israel 16.90% 59 Staff members of a veterinary hospital
(Verkade et al., 2014) [76] Jul 2008‑Dec 2009 The Netherlands 44.00% 137 Veterinarians
(Wettstein Rosenkranz et al., 2014) [77] 2012 Switzerland 2.73% 146 Veterinarians of small animals
(Wettstein Rosenkranz et al., 2014) [77] 2012 Switzerland 6.45% 31 Veterinarians of large animals
(Wettstein Rosenkranz et al., 2014) [77] 2012 Switzerland 4.50% 111 Veterinarians of general practice
(Ishihara et al., 2014) [78] 2008 Japan 22.90% 96 Veterinarian for dog and cats
(Ishihara et al., 2014) [78] 2008 Japan 10.00% 70 Veterinarian technician for dog and cats
(Paterson et al., 2013) [79] 2011 UK 2.60% 307 Cattle Veterinarians (Mostly)
(Boost et al., 2013) [80] Not specified Hong Kong, China 5.60% 300 Pork butchers
(Schwaber et al., 2013) [81] 2010 Israel 50.00% 20 Full‑time equine staff
(Schwaber et al., 2013) [81] 2010 Israel 4.55% 22 Community equine veterinarians
(Garcia‑Graells et al., 2012) [82] 2010 Belgium 8.90% 105 Livestock veterinarians
(Garcia‑Graells et al., 2012) [82] 2010 Denmark 2.10% 97 Livestock veterinarians
(Paul et al., 2011) [83] 2010 Italy 1.60% 128 Small animal dermatologists
(Jordan et al., 2011) [84] 2009 Australia 4.80% 250 Dog and cat veterinarians
(Jordan et al., 2011) [84] 2009 Australia 21.35% 89 Horse veterinarians
(Jordan et al., 2011) [84] 2009 Australia 8.33% 12 Pig veterinarians
(Zhang et al., 2011) [85] 2008–2009 China 1.96% 51 Small animal veterinary staff
(Horgan et al., 2011) [86] 2008 Ireland 2.00% 100 Pig Health Society Symposium attendees
(Ben Slama et al., 2011) [87] 2008–2009 Tunisia 1.20% 83 Veterinarian students or staff, farmers and 
abattoir workers
(Ishihara et al., 2010) [88] 2007 Japan 25.00% 20 Veterinarians
(Ishihara et al., 2010) [88] 2008 Japan 23.50% 34 Veterinarians
(Ishihara et al., 2010) [88] 2007 Japan 11.96% 92 Veterinary personnel
(Ishihara et al., 2010) [88] 2008 Japan 7.87% 127 Veterinary personnel
(Huber et al., 2010) [62] 2009 Switzerland 0.00% 148 Pig farmers
(Huber et al., 2010) [62] 2009 Switzerland 3.01% 133 Veterinarians
(Huber et al., 2010) [62] 2009 Switzerland 0.00% 179 Slaughterhouse employees
(Burstiner et al., 2010) [89] 2008 USA 17.30% 341 Veterinary surgeons and technicians
(Boost et al., 2011) [90] Not specified Hong Kong, China 0.67% 150 Veterinary personnel
(Heller et al., 2009) [91] Not specified Scotland, UK 3.13% 64 Small animal hospital staff members
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transmission of CC398 from animals to humans is con-
sidered difficult, as this strain does not usually persist 
in humans [50]. Nonetheless, this paradigm is chang-
ing and fatal cases of infection in humans with CC398 
have been reported [56]. Other strains of MRSA, such 
as CC97 which is transmitted between pigs and cattle in 
Italy, affect more than one animal species [96]. In addi-
tion, colonisation with MRSA is dependent on the dura-
tion of animal contact and the strain involved [50]. In this 
sense, farm workers who are frequently in close contact 
with animals are at a higher risk of acquiring MRSA, even 
more so than veterinarians whose duties include drug 
administration and necropsies. The age of the animals is 
also considered a risk factor. Younger pigs are more likely 
to be colonized with MRSA [64] and it is interesting that 
these younger pigs generally require the most intensive 
handling and care.
The higher prevalence of MRSA colonisation in vet-
erinarians from countries such as the Netherlands, 
Germany and USA can be explained by their having 
large pig herd sizes and intensive production systems. 
Although having smaller herd sizes, Austria also 
reported a higher prevalence of MRSA colonisation 
in swine veterinarians compared with non-swine vet-
erinarians. However, veterinary personnel from clinics 
and hospitals for small animals or horses also showed 
a high prevalence of MRSA colonisation worldwide. A 
study conducted in 2008 in Ireland reported a low prev-
alence of MRSA colonisation in pig industry person-
nel, and none of the samples found were CC398 MRSA 
[86]. After the first reported case of CC398 MRSA (spa 
t011) in 2012, other incidents of CC398 MRSA coloni-
sation have been reported on two Irish farms and in a 
veterinarian [97]. This demonstrates that natural barri-
ers, such as Ireland’s island status, are not sufficient in 
preventing MRSA spread unless they go in hand with a 
surveillance program which controls animal importa-
tions and strict on-farm biosecurity measures for per-
sonnel visiting or returning from abroad. Switzerland 
also reported a low prevalence for MRSA colonisation 
Table 1 (continued)
Study Year conducted Country Prevalence N Population
(Zemlicková et al., 2009) [92] 2008 Czech Republic 0.70% 280 261 Veterinary professionals (veterinarian and 
technician); 19 Pharmacist
(Meemken et al., 2008) [93] 2007 Germany 23.26% 86 Veterinarians, laboratory personnel and meat 
inspection personnel
(Moodley et al., 2008) [94] Aug 2006‑Feb 2007 Denmark 3.90% 231 Veterinarians (small and large animals)
(Moodley et al., 2008) [94] Aug 2006‑Feb 2008 Denmark 0.00% 98 Farmers
Fig. 1 MRSA spa types carried by humans in close contact with animals grouped by continent. Coloured boxes enclose the spa types reported in 
the studies summarised in Table 1. Countries whose prevalence was reported in Table 1 are highlighted in a darker colour
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among veterinarians, pig farmers and slaughterhouse 
employees in 2009. Over a decade later, the prevalence 
in veterinarians has increased along with the preva-
lence of MRSA in Swiss livestock [67], despite ongoing 
efforts to reduce antimicrobial usage [64]. This increase 
seems to be due to the spread of spa t034 among the 
swine herd there. The prevalence of MRSA in the Swiss 
pig population further increased with the rapid spread 
of spa t011, but this strain seems to be poorly adapted 
to colonising humans. Swiss cattle are also colonised by 
MRSA, but its increase in prevalence has been slower. 
As the importation of pigs into Switzerland is low and 
combined with the fact that many farms there have 
mixed livestock enterprises (pigs, cattle, poultry and/
or horses) could suggest that another species other than 
pigs may have acted as a reservoir of MRSA there.
Shouldn’t reduced antimicrobial usage decrease 
the prevalence of MRSA in farm settings?
Most European countries reduced antimicrobial con-
sumption in the period from 2010 to 2017 [98]. However, 
the prevalence of MRSA in animals has not decreased 
in these countries, but rather, in some (Finland, Spain 
and Switzerland) it has increased while in others it has 
remained stable (Germany and Norway) [99]. A possible 
explanation for this could be that once MRSA becomes 
endemic in a setting, it is difficult for other bacteria to 
compete and displace resistant strains. The selective pres-
sure of antibiotic use allows MRSA to thrive, whereas it is 
more difficult for the non-resistant bacteria to survive. In 
theory, if antibiotics are no longer used, other susceptible 
strains of S. aureus or other bacteria should out-compete 
MRSA due to the fitness cost of expressing the resistance 
genes. However, some MRSA strains possess resistance 
genes with low fitness-costs that allow them to compete 
and dominate hospital settings [100]. In a controlled 
environment, such as a hospital setting, reduced antimi-
crobial consumption in humans has proven effective in 
reducing MRSA presence [101], but these strategies do 
not necessarily decrease bacterial resistance [102]. Along 
with reducing antimicrobial use, what could be a more 
effective strategy for reducing MRSA levels in a setting 
is to frequently change the class of the antibiotics used 
[102, 103]. In this scenario, MRSA will not have a selec-
tive advantage over methicillin-susceptible strains if both 
are susceptible or resistant to the same prescribed anti-
biotic, and due to competition, susceptible strains will 
increase in circulation in detriment of MRSA. MRSA can 
also revert spontaneously to a susceptible strain if there 
is no selective pressure from antibiotics [104]. Nonethe-
less, if only the MRSA strain is resistant to the prescribed 
antibiotic, MRSA circulation will be enhanced. This 
frequent change in the class of antibiotic treatment has 
the potential to eliminate the bacterium, but it also has 
the risk of selecting for multi-drug resistance if treated 
strains are susceptible, as some of them may develop 
new resistances and survive the next change in antibiotic, 
accumulating resistance.
Another possible explanation as to why MRSA is 
increasing in prevalence on livestock farms is that 
humans can act as a reservoir for MRSA [105]. Research 
usually focuses on MRSA strains that are transmitted 
from animals to humans and the duration of the colo-
nisation. However, colonised humans are an important 
source for introducing MRSA onto the farm setting 
[106]. As an example, one of the outbreaks of MRSA in 
Norway happened through the introduction onto farms 
of CC1 MRSA, described mainly as an HA-MRSA, by a 
farm worker and spread through animal trading between 
farms [25]. Although CC1 has been described mainly 
as an HA-MRSA, it is not uncommon to find it in ani-
mals [107]. Therefore, we consider that the study of the 
transmission of MRSA from humans to animals should 
receive more attention, as it is likely that the spread of 
MRSA in livestock within and across countries may be 
due to animal contact with infected farm workers and/or 
veterinarians.
Alternative treatments for MRSA colonisation in animals
There is increasing concern worldwide regarding anti-
microbial resistance (AMR) because fewer options for 
treating immunocompromised patients will be available 
if AMR is not reduced. In 2016, the United Nations (UN) 
General Assembly discussed strategies for fighting AMR 
from a joint perspective (www. un. org/ pga/ 70/ events/ 
high- level- meeti ng- on- antim icrob ial- resis tance/). One 
of the greatest challenges that human health faces is the 
appearance of bacteria resistant to last resort antibiotics 
for humans and livestock species, such as vancomycin-
resistant S. aureus [108, 109]. It is important to note that 
some of the strategies to avoid the appearance of these 
new resistances include the elimination of last resort 
drugs from use in animal production. This policy is being 
applied in China, the main consumer of antimicrobials 
for veterinary use, although some European countries 
still retain the use of these drugs in farm settings [110]. 
Alongside the need to reduce antibiotic usage, there 
has been an increase in the number of studies look-
ing for alternative treatments to control/prevent MRSA 
colonisation.
Probiotics are one of the alternatives to antibiotics for 
the treatment and control of MRSA that have received 
most attention. The abundance of certain bacteria, such 
as lactic acid bacteria (Lactobacillus spp.), is negatively 
correlated with S. aureus abundance [111], which sug-
gests that these bacteria may inhibit MRSA growth. The 
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production of hydrogen peroxide  (H2O2) by vaginal lac-
tobacilli has been suggested as a possible bacteriostatic 
mechanism for reducing S. aureus levels [112, 113]. How-
ever, the low concentrations of  O2 found in the vaginal 
environment, which is required for  H2O2 production, 
suggests that the antimicrobial properties of Lactobacil-
lus spp. may be linked to production of another substance 
(e.g. lactic acid) which they produce in hypoxic environ-
ments [114]. Another mechanism in which Lactobacillus 
spp. might inhibit S. aureus colonisation is through the 
secretion of a biosurfactant that impedes the adhesion of 
S. aureus to surfaces [115]. Although most of the stud-
ies concerning the use of bacteria to control S. aureus 
have been performed in vitro, some have been conducted 
in vivo in mice and humans. The oral administration of 
Lactobacillus spp. reduced S. aureus carriage in the gas-
trointestinal tract of humans [116]. Whether consumed 
orally or administered in conjunction with nasal sprays, 
lactobacilli have also been used with the purpose of erad-
icating long-term nasal carriage of MRSA in humans. 
The mode of action of the lactobacilli here is thought to 
be mediated through stimulation of the upper respira-
tory immune system of the host. Nonetheless, such treat-
ments have not been completely effective [117, 118].
With the global trend towards reducing antimicrobial 
usage in livestock, the use of probiotics in food-produc-
ing animals seems a viable alternative. The addition of 
probiotics, such as Bacillus subtilis, to feed can improve 
feed efficiency in pigs whilst these probiotics also possess 
in vitro inhibitory activity over S. aureus [119]. The action 
of B. subtilis against S. aureus is mediated through the 
use of fengycins, a lipopeptide that inhibits quorum sens-
ing in S. aureus colonies, impairing their ability to per-
ceive their population density and act in response with 
genetic adaptations [120]. In staphylococcal infections, 
quorum sensing regulates, among others, toxin produc-
tion, the expression of colonisation factors and biofilm 
formation [121]. Of note, the presence of B. subtillis in 
the human intestine was associated with the absence of S. 
aureus not only in the intestine, but also in the nasal pas-
sage, even though B. subtilis was seldom found colonising 
the airways of subjects [120].
Bacteria from various environments have been 
evaluated to ‘mine’ new probiotics with bacteriostatic 
activity against MRSA. For example, in an Irish study, 
Streptomyces sp. myrophorea recovered from soil has 
been reported to have activity against several patho-
gens, including MRSA [122]. Other approaches have 
studied the microbial ecology of the host using 16S 
rRNA gene sequencing and considered the co-abun-
dance of the bacteria present to analyse those species 
positively and negatively correlated with MRSA. In one 
such study, S. aureus colonisation was seldom found 
in the nasal passages of pigs when other staphylococci 
species (S. sciuri, S. cohnii, and S. saprophyticus) were 
present [123].
Another possible alternative for reducing MRSA car-
riage is the use of bacteriophage therapies. The treatment 
of staphylococcal skin lesions was the target of one of the 
first bacteriophage therapies used [124]. However, phage 
therapies were relegated to a second place in Western 
medicine a few decades later because of the wide-spread 
use of antibiotics [125]. In recent years, phage therapy 
research has again resurfaced to find alternatives to anti-
microbial treatments. Clinical trials in mice have shown 
that bacteriophage administration can protect against 
lethal MRSA infections and reduce S. aureus levels in the 
nasal passages [126, 127]. Although promising, clinical 
trials with bacteriophage therapies are still rare due to a 
number of challenges, including the possibility of MRSA 
acquiring resistance to the phage, side effects of bacte-
rial lysis, governmental constraints and public reticence 
towards administration of a self-replicating agent [125, 
128].
Eradication strategies
MRSA can be eradicated from hospitals by implement-
ing strict hygiene measures and controlling the environ-
ment. For instance, ‘search and destroy’ policies were 
applied in the Netherlands and Denmark reducing the 
spread of both HA- and CA-MRSA in health-care set-
tings [129, 130]. In these strategies, screening for MRSA 
carriage is performed on patients and health-care work-
ers. Thereafter, all the individuals positive for MRSA are 
isolated and treated, when possible, in order to eliminate 
MRSA carriage. Similar preventive measures have been 
applied in the U.S., such as in the REDUCE-MRSA trial, 
which reported a 37% reduction of MRSA carriage when 
universal decolonisation was practiced on all patients in 
the same intensive care units (ICUs) through intranasal 
mupirocin application and bathing with cloths impreg-
nated in chlorhexidine [131]. Measures for the preven-
tion and control of MRSA infections and the interruption 
of its transmission in U.S. hospital settings were success-
ful in reducing the incidence of HA-MRSA bacteraemia 
in the last few decades [132]. However, the rate of decline 
in HA-MRSA infections has slowed since 2012 in the 
U.S., while at the same time the incidence of CA-MRSA 
infections has increased slightly. This suggests the need 
for new preventive measures [132].
In 2013, Norway commenced a national control strat-
egy to eradicate MRSA from pig farms [40]. The strategy 
involves the annual screening of all pig herds but also a 
surveillance program of the human population, following 
the “One Health” approach. Information from reported 
human MRSA cases in hospitals allows the tracing of 
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MRSA spread across Norway. Furthermore, introduc-
tion of MRSA into pig herds in Norway from abroad can 
easily be traced since Norwegian pig production is a par-
ticularly closed system, with few stock importations [40]. 
The Norwegian eradication campaign follows a series of 
steps, starting with an annual screening of the pig popu-
lation. When a farm is found to be positive for MRSA, 
trade in live animals is restricted, and farms are depop-
ulated followed by thorough washing and disinfection. 
Once confirmed free of MRSA, the farm is re-stocked 
with pigs from MRSA negative herds. Even then, ani-
mals from the restocked farm are screened again before 
reaching the slaughterhouse to assess the success of 
MRSA eradication [40]. As part of the programme, farm 
staff and their relatives are screened for MRSA carriage. 
There are increased restrictions on visiting Norwegian 
pig farms, especially if the visitor is from abroad, to help 
limit potential colonisation. It would seem that this strict, 
expensive and time-consuming eradication programme is 
effective as the prevalence of MRSA in Norwegian pigs 
has been kept low (< 0.5%) [99].
Suggestions to prevent MRSA introduction onto farms
The introduction of MRSA onto a farm can occur via 
different routes. The most important of these being the 
movement of MRSA colonised animals from one farm 
to another, direct contact with colonised humans and 
through animal contact with contaminated transport 
vehicles [38–40]. For this reason, good external biosecu-
rity protocols should be adhered to when importing live 
animals onto a farm. Stock to be introduced should only 
be purchased from MRSA-negative herds. They should 
be quarantined at 550 m from the rest of the herd for a 
minimum period of 6  weeks as it has been shown that 
MRSA can be airborne and spread in this manner [42, 43, 
133]. Animals should be screened for MRSA during quar-
antine and only allowed join the main herd when shown 
to be MRSA-negative. Gloves should be worn when ani-
mals are handled and all humans working or visiting the 
farm should shower in before entering and shower out 
when exiting the farm [36]. The number of visitors enter-
ing the farm should be kept to a minimum, but when 
necessary, visitors should not have been on another farm 
in the previous 48 h as LA-MRSA can still be carried dur-
ing that period [134]. Furthermore, farm visitors should 
wear masks to reduce transmission to the herd [135]. 
Meat products should not be permitted on the farm, as 
MRSA can also survive in them [45, 46].
Antimicrobial use on farms should be minimised. 
When MRSA first enters a farm, antimicrobial use helps 
to select for MRSA strains, to the detriment of the non-
resistant strains [39]. In a model to assess the efficacy 
of interventions on the spread of MRSA on Danish pig 
farms, reducing antimicrobial use, restricting movement 
of animals and reducing human transmission were pre-
dicted to be highly effective when introduced in a low 
MRSA prevalence area [106]. However, these measures 
need to be implemented before an endemic situation 
occurs, otherwise much stricter control measures, like 
those in Norway, will be required, such as culling a per-
centage of MRSA positive herds.
Conclusion
Despite reduced antimicrobial usage in European animal 
production in recent years, the prevalence of MRSA in 
farm animals has not declined. It is therefore likely that, 
MRSA persists in other reservoirs, such as in humans 
(i.e. farm workers and veterinarians). In highly colonised 
farms, strategies involving reducing the reliance on anti-
biotic usage and the frequent change of antibiotic classes 
used should be considered for reducing MRSA levels. 
Control and treatment strategies such as, strict preven-
tive biosecurity measures, selective probiotic feeding and 
MRSA eradication programmes should be used to pre-
vent MRSA entering a farm, reduce MRSA carriage and 
eradicate MRSA from infected farms, respectively. Doing 
so will help to prevent a future where antibiotics are no 
longer an effective treatment for MRSA infections in ani-
mals and humans.
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